Literature DB >> 19536607

Discrepancy between serum levels of low molecular weight proteins in acute kidney injury model rats with bilateral ureteral obstruction and bilateral nephrectomy.

Hidetoshi Tsuda1, Yoshitaka Isaka, Shiro Takahara, Masaru Horio.   

Abstract

BACKGROUND: Serum levels of low molecular weight (LMW) proteins, such as cystatin C and beta-2-microglobulin (MG), are used as GFR markers. Ureteral obstruction is a cause of acute kidney injury (AKI). However, it is unclear whether serum concentrations of LMW proteins are increased in postrenal AKI like in intrinsic AKI. To evaluate this question, the responses of serum levels of cystatin C and beta-2-MG were investigated in rats with bilateral ureteral obstruction (BUO) and bilateral nephrectomy (BNX).
METHODS: Sixteen SD rats were divided into sham (sham operated), BUO and BNX groups. Serum levels of creatinine, BUN, cystatin C, beta 2-MG and creatine phosphokinase (CPK) were measured after 24 h of the treatments. Cystatin C and beta 2-MG were measured using rat ELISA kits.
RESULTS: In the sham group, the mean +/- SD of creatinine, BUN, cystatin C and beta-2-MG were 0.19 +/- 0.01 mg/dl, 22.6 +/- 1.9 mg/dl, 1.27 +/- 0.18 mg/l and 3.57 +/- 0.42 mg/l, respectively. Following BNX, the values significantly rose to 4.79 +/- 0.17 mg/dl, 116.9 +/- 2.6 mg/dl, 2.59 +/- 0.18 mg/l and 9.03 +/- 0.52 mg/l compared with sham, respectively. Following BUO, they were 3.99 +/- 0.25 mg/dl, 130.3 +/- 12.9 mg/dl, 1.94 +/- 0.35 mg/l and 4.78 +/- 0.24 mg/l, respectively. Increasing amounts of creatinine and BUN in BUO were similar to those in BNX. On the other hand, cystatin C and beta-2 MG in BUO were much lower compared with BNX (P < 0.01 and <0.001, respectively). Fold increases of cystatin C and beta-2-MG in BUO were only 51% and 22% of those in BNX, respectively. There was no significant difference in CPK levels between the BUO and BNX groups.
CONCLUSION: We showed a discrepancy between serum levels of LMW proteins in AKI model rats with BUO and BNX. The reasons for the discrepancy are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536607     DOI: 10.1007/s10157-009-0203-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  11 in total

Review 1.  Creatine: biosynthesis, regulation, and function.

Authors:  J B Walker
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

2.  Cystatin C in a rat model of end-stage renal failure.

Authors:  A Bökenkamp; G Ciarimboli; C Dieterich
Journal:  Ren Fail       Date:  2001 May-Jul       Impact factor: 2.606

3.  Altered expression of major renal Na transporters in rats with bilateral ureteral obstruction and release of obstruction.

Authors:  Chunling Li; Weidong Wang; Tae-Hwan Kwon; Mark A Knepper; Søren Nielsen; Jørgen Frøkiaer
Journal:  Am J Physiol Renal Physiol       Date:  2003-07-15

Review 4.  Diagnostic value of analysis of cystatin C and protein HC in biological fluids.

Authors:  A Grubb
Journal:  Clin Nephrol       Date:  1992       Impact factor: 0.975

5.  Renal blood flow and vasodilatory ability prior to and following release of 24 hours bilateral ureteral obstruction in rats.

Authors:  A Hope; G Clausen
Journal:  Acta Physiol Scand       Date:  1984-08

6.  The effect of growth hormone and thyroxine on the amount of L-arginine:glycine amidinotransferase in kidneys of hypophysectomized rats. Purification and some properties of rat kidney transamidinase.

Authors:  D M McGuire; C D Tormanen; I S Segal; J F Van Pilsum
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

7.  Relationship between urinary and serum growth hormone and pubertal status.

Authors:  E C Crowne; W H Wallace; S M Shalet; G M Addison; D A Price
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

Review 8.  Effects of obstruction on renal functions.

Authors:  S Klahr; K Harris; M L Purkerson
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

9.  Isolated nephron segments from rabbit models of obstructive nephropathy.

Authors:  M J Hanley; K Davidson
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

10.  Renal cortical blood flow distribution in obstructive nephropathy in rats.

Authors:  N J Siegel; R A Feldman; B Lytton; J P Hayslett; M Kashgarian
Journal:  Circ Res       Date:  1977-04       Impact factor: 17.367

View more
  6 in total

1.  Insufficient performance of serum cystatin C as a biomarker for acute kidney injury of postrenal etiology.

Authors:  Julia Hasslacher; Georg F Lehner; Michael Joannidis
Journal:  Intensive Care Med       Date:  2011-10-01       Impact factor: 17.440

Review 2.  Acute and chronic kidney injury in nephrolithiasis.

Authors:  Xiaojing Tang; John C Lieske
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-07       Impact factor: 2.894

3.  The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis.

Authors:  Masahiro Matsuki; Toshiaki Tanaka; Takeshi Maehana; Yuki Kyoda; Koji Ichihara; Kohei Hashimoto; Masahiro Yanase; Masanori Matsukawa; Hideki Adachi; Satoshi Takahashi; Naoya Masumori
Journal:  Clin Exp Nephrol       Date:  2017-03-03       Impact factor: 2.801

4.  Discrepancy between cystatin C and creatinine points leading to a diagnosis of postrenal acute kidney injury and its reversibility: three case reports.

Authors:  Nao Fujisawa; Masatomo Yashiro; Hiroyoshi Segawa; Yuko Kadoya; Tadashi Kamata
Journal:  Clin Exp Nephrol       Date:  2010-07-06       Impact factor: 2.801

5.  Gene expression plasticity and desert adaptation in house mice.

Authors:  Noëlle K J Bittner; Katya L Mack; Michael W Nachman
Journal:  Evolution       Date:  2021-01-23       Impact factor: 4.171

6.  Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injury.

Authors:  Salih İnal; Atila Altuntaş; Veysel Kidir; Alper Özorak; Yusuf İlgin; Mehmet Tugrul Sezer
Journal:  J Res Med Sci       Date:  2014-11       Impact factor: 1.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.